500 related articles for article (PubMed ID: 10091391)
21. Analysis of factors affecting PBPC collection in low-weight children with malignant disorders.
Delgado J; Fernandez-Jimenez MC; Martinez A; Sastre A; Garcia-Miguel P; Hernandez-Navarro F; Arrieta R
Cytotherapy; 2004; 6(1):43-9. PubMed ID: 14985166
[TBL] [Abstract][Full Text] [Related]
22. Optimization of CD34+ collection for autologous transplantation using the evolution of peripheral blood cell counts after mobilization with chemotherapy and G-CSF.
Delamain MT; Metze K; Marques JF; Reis AR; De Souza CA; Lorand-Metze I
Transfus Apher Sci; 2006 Feb; 34(1):33-40. PubMed ID: 16376618
[TBL] [Abstract][Full Text] [Related]
23. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis.
Schots R; Van Riet I; Damiaens S; Flament J; Lacor P; Staelens Y; Steenssens L; van Camp B; De Waele M
Bone Marrow Transplant; 1996 Apr; 17(4):509-15. PubMed ID: 8722347
[TBL] [Abstract][Full Text] [Related]
24. PBPC collection techniques: standard versus large volume leukapheresis (LVL) in donors and in patients.
Gasová Z; Marinov I; Vodvárková S; Böhmová M; Bhuyian-Ludvíková Z
Transfus Apher Sci; 2005 Apr; 32(2):167-76. PubMed ID: 15784451
[TBL] [Abstract][Full Text] [Related]
25. A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma.
Bruns I; Steidl U; Kronenwett R; Fenk R; Graef T; Rohr UP; Neumann F; Fischer J; Scheid C; Hübel K; Haas R; Kobbe G
Transfusion; 2006 Feb; 46(2):180-5. PubMed ID: 16441592
[TBL] [Abstract][Full Text] [Related]
26. Ancestim (recombinant human stem cell factor, SCF) in association with filgrastim does not enhance chemotherapy and/or growth factor-induced peripheral blood progenitor cell (PBPC) mobilization in patients with a prior insufficient PBPC collection.
da Silva MG; Pimentel P; Carvalhais A; Barbosa I; Machado A; Campilho F; Sousa SR; Miranda N; da Costa FL; Campos A; Vaz CP; Antas J; Passos-Coelho JL
Bone Marrow Transplant; 2004 Oct; 34(8):683-91. PubMed ID: 15322567
[TBL] [Abstract][Full Text] [Related]
27. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
28. Large volume leukapheresis in small children: safety profile and variables affecting peripheral blood progenitor cell collection.
Sevilla J; González-Vicent M; Madero L; García-Sánchez F; Angel Diaz M
Bone Marrow Transplant; 2003 Feb; 31(4):263-7. PubMed ID: 12621460
[TBL] [Abstract][Full Text] [Related]
29. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
Körbling M; Anderlini P; Durett A; Maadani F; Bojko P; Seong D; Giralt S; Khouri I; Andersson B; Mehra R; vanBesien K; Mirza N; Przepiorka D; Champlin R
Bone Marrow Transplant; 1996 Dec; 18(6):1073-9. PubMed ID: 8971375
[TBL] [Abstract][Full Text] [Related]
30. Kinetics of standardized large volume leukapheresis (LVL) in patients do not show a recruitment phenomenon of peripheral blood progenitor cells (PBPC).
Cassens U; Momkvist PH; Zuehlsdorf M; Mohr M; Kienast J; Berdel WE; Sibrowski W
Bone Marrow Transplant; 2001 Jul; 28(1):13-20. PubMed ID: 11498739
[TBL] [Abstract][Full Text] [Related]
31. Mobilization and harvesting of peripheral blood stem cells in pediatric patients with solid tumors.
Veljkovic D; Vujic D; Nonkovic OS; Jevtic D; Zecevic Z; Lazic E
Ther Apher Dial; 2011 Dec; 15(6):579-86. PubMed ID: 22107695
[TBL] [Abstract][Full Text] [Related]
32. Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells.
Abrahamsen JF; Stamnesfet S; Liseth K; Hervig T; Bruserud O
Transfusion; 2005 Feb; 45(2):248-53. PubMed ID: 15660835
[TBL] [Abstract][Full Text] [Related]
33. A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters.
Demirer T; Dagli M; Ilhan O; Ayli M; Haznedar R; Fen T; Gunel N; Genc Y; Arat M; Ozcan M; Arslan O; Seyrek E; Dincer S; Ustun T; Ustael N; Koc H; Muftuoglu O; Akan H
Bone Marrow Transplant; 2002 Jun; 29(11):893-7. PubMed ID: 12080353
[TBL] [Abstract][Full Text] [Related]
34. Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients.
Bochennek K; Andreas C; Margraf C; Stahlkamp H; Zimmermann S; Esser R; Schwabe D; Klingebiel T; Grüttner HP; Koehl U
Bone Marrow Transplant; 2005 Sep; 36(6):481-9. PubMed ID: 16044142
[TBL] [Abstract][Full Text] [Related]
35. Circulating CD34+ cell counts as predictive parameter for the efficacy of peripheral stem cell apheresis in Ewing tumor patients.
Engel BC; Laws HJ; Dirksen U; Kramm CM; Göbel U; Burdach SE
Klin Padiatr; 1997; 209(4):186-90. PubMed ID: 9293449
[TBL] [Abstract][Full Text] [Related]
36. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.
Jacoub JF; Suryadevara U; Pereyra V; Colón D; Fontelonga A; Mackintosh FR; Hall SW; Ascensão JL
Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563
[TBL] [Abstract][Full Text] [Related]
37. A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma.
Stiff P; Gingrich R; Luger S; Wyres MR; Brown RA; LeMaistre CF; Perry J; Schenkein DP; List A; Mason JR; Bensinger W; Wheeler C; Freter C; Parker WRL ; Emmanouilides C
Bone Marrow Transplant; 2000 Sep; 26(5):471-81. PubMed ID: 11019835
[TBL] [Abstract][Full Text] [Related]
38. Improving the efficiency of PBPC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cells.
Lane TA; Bashey A; Carrier E; Holman P; Castro J; Mullen M; Ward DM; Ada O; Ball ED
Cytotherapy; 2004; 6(4):318-27. PubMed ID: 16146884
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis.
Lefrère F; Zohar S; Beaudier S; Audat F; Ribeil JA; Ghez D; Varet B; Cavazzana-Calvo M; Dal Cortivo L; Letestu R; McIntyre E; Brouzes C
Transfusion; 2007 Oct; 47(10):1851-7. PubMed ID: 17880611
[TBL] [Abstract][Full Text] [Related]
40. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
Callera F; Cavenaghi L; de Melo CM
Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
